Use of n-acetylcysteine amide in the treatment of acetaminophen overdose
OwnerGlenn A. Goldsteininventor
Life of this patent
Estimating the term…
Abstract
This disclosure describes pharmaceutical compositions and methods of use for N-acetylcysteine amide for the prevention and treatment of acetaminophen overdose.
Claims27
A pharmaceutical composition comprising 600-1200 mg of acetaminophen and 100-10,000 mg of N-acetylcysteine amide (NACA).
A method of treating pain comprising in a subject in need thereof comprising administering to the subject a pharmaceutical composition comprising 600-1200 mg of acetaminophen and 100-10,000 mg of N-acetylcysteine amide (NACA).
A method of treating N-acetyl-p-aminophenol (APAP) toxicity in a subject in need thereof comprising administering to the subject a therapeutically effective amount of NACA.
Dependencies are inferred from the claim text.